Cargando…

Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice

Human mesenchymal stem cells (MSCs) represent a novel carrier for gene therapy and apoptin is a potential tumor-selective apoptosis-inducing protein. In the present study, the anti-tumoral effect of MSCs modified with apoptin against lung carcinoma was evaluated. Apoptin protein was expressed in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: DU, JINGCHUN, ZHANG, YANLING, XU, CHUN, XU, XIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438975/
https://www.ncbi.nlm.nih.gov/pubmed/25816208
http://dx.doi.org/10.3892/mmr.2015.3501
_version_ 1782372431616278528
author DU, JINGCHUN
ZHANG, YANLING
XU, CHUN
XU, XIA
author_facet DU, JINGCHUN
ZHANG, YANLING
XU, CHUN
XU, XIA
author_sort DU, JINGCHUN
collection PubMed
description Human mesenchymal stem cells (MSCs) represent a novel carrier for gene therapy and apoptin is a potential tumor-selective apoptosis-inducing protein. In the present study, the anti-tumoral effect of MSCs modified with apoptin against lung carcinoma was evaluated. Apoptin protein was expressed in a prokaryotic expression system and purified by affinity chromatography. Subsequently, anti-apoptin antibody was prepared by immunizing BALB/c mice with purified apoptin protein. Human MSCs were isolated, amplified and transduced with lentiviral vectors encoding full-length apoptin, in which the secretory signal and protein transduction sequence were added into the amino terminus to assist apoptin in entering into target cells. The differentiation and apoptin expression of apoptin-modified MSCs were confirmed. Subsequently, the anti-tumor effect of apoptin-modified MSCs was measured in vitro and in vivo. Following modification with apoptin, MSCs retained their differentiation capacity, and successfully synthesized and secreted apoptin, which entered target cells and selectively induced lung cancer cell apoptosis through activating caspase-3. The percentage of tumor cells with activated caspase-3 in the apoptin-modified MSCs group was markedly higher than that in the MSCs group (16.5±2.9% at 24 h and 27.3±2.0% at 48 h vs. 3.4±1.1% at 24 h and 2.2±0.6% at 48 h). When injected into nude mice, apoptin-modified MSCs inhibited the growth of lung carcinoma compared with that in the control groups (0.14±0.02 g vs. 0.21±0.04 g vs. 0.31±0.05 g, P<0.05). The results of the present study provided preclinical support of apoptin-based cancer therapy with MSCs as cellular vehicles.
format Online
Article
Text
id pubmed-4438975
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-44389752015-06-05 Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice DU, JINGCHUN ZHANG, YANLING XU, CHUN XU, XIA Mol Med Rep Articles Human mesenchymal stem cells (MSCs) represent a novel carrier for gene therapy and apoptin is a potential tumor-selective apoptosis-inducing protein. In the present study, the anti-tumoral effect of MSCs modified with apoptin against lung carcinoma was evaluated. Apoptin protein was expressed in a prokaryotic expression system and purified by affinity chromatography. Subsequently, anti-apoptin antibody was prepared by immunizing BALB/c mice with purified apoptin protein. Human MSCs were isolated, amplified and transduced with lentiviral vectors encoding full-length apoptin, in which the secretory signal and protein transduction sequence were added into the amino terminus to assist apoptin in entering into target cells. The differentiation and apoptin expression of apoptin-modified MSCs were confirmed. Subsequently, the anti-tumor effect of apoptin-modified MSCs was measured in vitro and in vivo. Following modification with apoptin, MSCs retained their differentiation capacity, and successfully synthesized and secreted apoptin, which entered target cells and selectively induced lung cancer cell apoptosis through activating caspase-3. The percentage of tumor cells with activated caspase-3 in the apoptin-modified MSCs group was markedly higher than that in the MSCs group (16.5±2.9% at 24 h and 27.3±2.0% at 48 h vs. 3.4±1.1% at 24 h and 2.2±0.6% at 48 h). When injected into nude mice, apoptin-modified MSCs inhibited the growth of lung carcinoma compared with that in the control groups (0.14±0.02 g vs. 0.21±0.04 g vs. 0.31±0.05 g, P<0.05). The results of the present study provided preclinical support of apoptin-based cancer therapy with MSCs as cellular vehicles. D.A. Spandidos 2015-07 2015-03-17 /pmc/articles/PMC4438975/ /pubmed/25816208 http://dx.doi.org/10.3892/mmr.2015.3501 Text en Copyright © 2015, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
DU, JINGCHUN
ZHANG, YANLING
XU, CHUN
XU, XIA
Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
title Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
title_full Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
title_fullStr Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
title_full_unstemmed Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
title_short Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
title_sort apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438975/
https://www.ncbi.nlm.nih.gov/pubmed/25816208
http://dx.doi.org/10.3892/mmr.2015.3501
work_keys_str_mv AT dujingchun apoptinmodifiedhumanmesenchymalstemcellsinhibitgrowthoflungcarcinomainnudemice
AT zhangyanling apoptinmodifiedhumanmesenchymalstemcellsinhibitgrowthoflungcarcinomainnudemice
AT xuchun apoptinmodifiedhumanmesenchymalstemcellsinhibitgrowthoflungcarcinomainnudemice
AT xuxia apoptinmodifiedhumanmesenchymalstemcellsinhibitgrowthoflungcarcinomainnudemice